Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Colonic Neoplasms × capivasertib × Clear all

Sponsor

Conditions

Triple Negative Breast Neoplasms 2 Recurrence 1 Neoplasms 1 Multiple Myeloma 1 Lymphoma, Mantle-Cell 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma, B-Cell 1 Lymphoma 1 Locally Advanced (Inoperable) or Metastatic Breast Cancer 1 Hematologic Neoplasms 1 Carcinosarcoma 1 Carcinoma, Endometrioid 1 Breast Neoplasms 1 Advanced Solid Malignancy, 1

Interventions

Leucovorin 38 Fluorouracil 36 Oxaliplatin 34 Bevacizumab 34 Irinotecan 32 Cetuximab 23 Capecitabine 18 Panitumumab 14 IFL protocol 7 Folfox protocol 6 Radiotherapy 5 Nivolumab 5 Magnetic Resonance Spectroscopy 5 Immunohistochemistry 5 Gene Expression Profiling 5 Celecoxib 5 regorafenib 4 pembrolizumab 4 dehydroftorafur 4 Ramucirumab 4 Fluorodeoxyglucose F18 4 Floxuridine 4 aflibercept 3 Surgical Procedures, Operative 3 Sorafenib 3 Radiosurgery 3 Ipilimumab 3 Gemcitabine 3 Fentanyl 3 Drug Therapy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡